Literature DB >> 21942880

Chondroitin 4-O-sulfotransferase-2 regulates the number of chondroitin sulfate chains initiated by chondroitin N-acetylgalactosaminyltransferase-1.

Tomomi Izumikawa1, Toshiyasu Koike, Hiroshi Kitagawa.   

Abstract

Recently, it has been shown that a deficiency in ChGn-1 (chondroitin N-acetylgalactosaminyltransferase-1) reduced the numbers of CS (chondroitin sulfate) chains, leading to skeletal dysplasias in mice. Although these results indicate that ChGn-1 regulates the number of CS chains, the mechanism mediating this regulation is not clear. ChGn-1 is thought to initiate CS biosynthesis by transferring the first GalNAc (N-acetylgalactosamine) to the tetrasaccharide in the protein linkage region of CS. However, in vitro chondroitin polymerization does not occur on the non-reducing terminal GalNAc-linkage pentasaccharide structure. In the present study we show that several different heteromeric enzyme complexes composed of different combinations of four chondroitin synthase family members synthesized more CS chains when a GalNAc-linkage pentasaccharide structure with a non-reducing terminal 4-O-sulfation was the CS acceptor. In addition, C4ST-2 (chondroitin 4-O-sulfotransferase-2) efficiently transferred sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of non-reducing terminal GalNAc-linkage residues, and the number of CS chains was regulated by the expression levels of C4ST-2 and of ChGn-1. Taken together, the results of the present study indicate that C4ST-2 plays a key role in regulating levels of CS synthesized via ChGn-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21942880     DOI: 10.1042/BJ20111472

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1.

Authors:  Tomomi Izumikawa; Ban Sato; Tadahisa Mikami; Jun-ichi Tamura; Michihiro Igarashi; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 2.  Sulfated glycosaminoglycans: their distinct roles in stem cell biology.

Authors:  Tadahisa Mikami; Hiroshi Kitagawa
Journal:  Glycoconj J       Date:  2016-10-06       Impact factor: 2.916

Review 3.  Modifications of glycans: biological significance and therapeutic opportunities.

Authors:  Saddam M Muthana; Christopher T Campbell; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

4.  Dermatan sulfate epimerase 1 and dermatan 4-O-sulfotransferase 1 form complexes that generate long epimerized 4-O-sulfated blocks.

Authors:  Emil Tykesson; Antti Hassinen; Katarzyna Zielinska; Martin A Thelin; Giacomo Frati; Ulf Ellervik; Gunilla Westergren-Thorsson; Anders Malmström; Sakari Kellokumpu; Marco Maccarana
Journal:  J Biol Chem       Date:  2018-07-05       Impact factor: 5.157

5.  Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans.

Authors:  Toshiyasu Koike; Tomomi Izumikawa; Ban Sato; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

6.  Refined mapping of a hypertension susceptibility locus on rat chromosome 12.

Authors:  Sasha Z Prisco; Jeremy W Prokop; Allison B Sarkis; Nan Cher Yeo; Matthew J Hoffman; Colin C Hansen; Howard J Jacob; Michael J Flister; Jozef Lazar
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

7.  Chondroitin / dermatan sulfate modification enzymes in zebrafish development.

Authors:  Judith Habicher; Tatjana Haitina; Inger Eriksson; Katarina Holmborn; Tabea Dierker; Per E Ahlberg; Johan Ledin
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Chondroitin sulfate-E mediates estrogen-induced osteoanabolism.

Authors:  Toshiyasu Koike; Tadahisa Mikami; Miharu Shida; Osami Habuchi; Hiroshi Kitagawa
Journal:  Sci Rep       Date:  2015-03-11       Impact factor: 4.379

Review 9.  Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

Review 10.  Metabolism of cartilage proteoglycans in health and disease.

Authors:  Demitrios H Vynios
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.